13F-HR filed by Whitefort Capital Management, LP
Whitefort Capital Management, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 21 holding rows worth $156,860,913.
- Accession
- 0001013594-24-000195
- Filer
- CIK 1884931
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 21 entries on the cover page, a total value of $156,860,913 stated on the cover page (in dollars after the unit check, H1), rows summing to $156,860,913 with VALUE read as dollars as filed, 13F file number 028-22014. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GLOBAL SHIP LEASE INC | Y27183600 | COM CL A | 1,897,481 | $37,608,073 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 13,197,062 | $32,992,655 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,591,000 | $17,866,930 | dollars as filed | |
| LIBERTY MEDIA CORP DEL | 531229789 | COM LBTY SRM S | 456,285 | $13,131,882 | dollars as filed | |
| NEXTNAV INC | 65345N106 | COMMON STOCK | 2,610,907 | $11,618,536 | dollars as filed | |
| GENWORTH FINL INC | 37247D106 | COM SHS | 1,517,272 | $10,135,377 | dollars as filed | |
| SABRE GLBL INC | 78573NAE2 | BOND | 5,000,000 | $4,869,074 | dollars as filed | principal |
| MAIDEN HOLDINGS LTD | G5753U112 | SHS | 1,965,795 | $4,501,671 | dollars as filed | |
| LIBERTY MEDIA CORP DEL | 531229722 | COM LBTY LIV S C | 114,071 | $4,265,115 | dollars as filed | |
| THE CENTRAL AND EASTERN EU I | 153436100 | COM | 305,015 | $2,973,896 | dollars as filed | |
| Esperion Therapeutics Inc | 29664WAB1 | NOTE 4.000%11/15/25 | 4,900,000 | $2,848,125 | dollars as filed | principal |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 231,558 | $2,785,643 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 885,522 | $2,647,711 | dollars as filed | |
| ODYSSEY MARINE EXPL INC | 676118201 | COM NEW | 548,909 | $2,552,427 | dollars as filed | |
| INNOVATE CORP | 404139AG2 | NOTE 7.500% 8/0 | 5,658,000 | $2,536,481 | dollars as filed | principal |
| PITNEY BOWES INC COM | 724479100 | Stock | 373,500 | $1,643,400 | dollars as filed | |
| INNOVATE CORP | 45784J105 | COM | 1,089,118 | $1,339,615 | dollars as filed | |
| NEXTNAV INC | 65345N114 | *W EXP 99/99/999 | 482,951 | $347,725 | dollars as filed | |
| TRINITY BIOTECH PLC | 896438306 | SPON ADR NEW | 409,517 | $175,683 | dollars as filed | |
| LANVIN GROUP HOLDINGS LIMITE | G5380J118 | W EXP 01/14/202 | 100,000 | $14,000 | dollars as filed | |
| ALTENERGY ACQUISITION CORP | 02157M116 | *W EXP 10/29/202 | 186,315 | $6,894 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-24-000195 | this filing | 2024-02-14 | acceptance time not in the bulk data set |